Search by Drug Name or NDC
NDC 10135-0732-01 Mexiletine Hydrochloride 250 mg/1 Details
Mexiletine Hydrochloride 250 mg/1
Mexiletine Hydrochloride is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Marlex Pharmaceuticals, Inc.. The primary component is MEXILETINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Mexiletine is used to treat certain types of ventricular arrhythmias (abnormal heart rhythms). Mexiletine is in a class of medications called antiarrhythmics. It works by blocking certain electrical signals in the heart to stabilize the heart rhythm.
Related Packages: 10135-0732-01Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mexiletine
Product Information
| NDC | 10135-0732 |
|---|---|
| Product ID | 10135-732_09bc0907-5c76-ce4f-e063-6294a90a5b6f |
| Associated GPIs | 35200025100115 |
| GCN Sequence Number | 000269 |
| GCN Sequence Number Description | mexiletine HCl CAPSULE 250 MG ORAL |
| HIC3 | A2A |
| HIC3 Description | ANTIARRHYTHMICS |
| GCN | 12212 |
| HICL Sequence Number | 000084 |
| HICL Sequence Number Description | MEXILETINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Mexiletine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Mexiletine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/1 |
| Substance Name | MEXILETINE HYDROCHLORIDE |
| Labeler Name | Marlex Pharmaceuticals, Inc. |
| Pharmaceutical Class | Antiarrhythmic [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213500 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 10135-0732-01 (10135073201)
| NDC Package Code | 10135-732-01 |
|---|---|
| Billing NDC | 10135073201 |
| Package | 100 CAPSULE in 1 BOTTLE (10135-732-01) |
| Marketing Start Date | 2022-02-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |